Cancer is a chronic disease that involves the abnormal growth of cells inside the body, which further results in the formation of tumor. If untreated, the tumor grows, and hampers the ability of the lungs to provide oxygen to the blood stream. Lung cancer is the malignant tumor and is the second most diagnosed cancer that has the highest mortality rate in both men and women. The lung cancer is primarily classified into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). SCLC is a critical medical condition as compared to NSCLC due to its size and lack of availability of drug treatment. Some of the symptoms of lung cancer include coughing, shortness of breath, weight loss, chest pain and others. Chemotherapy, radiation therapy, and others are used in the treatment of lung cancer.
Top Companies Of Lung Cancer Therapeutics:
- Astrazeneca plc
- Eli Lilly and Company
- GlaxoSmitKline plc
- F Hoffman La Roche Ltd.
- Boehringer Ingelheim GmbH
- Pfizer Inc.
- Sanofi Aventis
- ArQule Inc.
- Daiichi Sankyo Co. Ltd
- Agennix AG
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-toc-and-sample/4253
Lung Cancer Therapeutics Market Segmentation can be done based on several factors, including:
By Chemotherapy
- Navelbine
- Hycamtin
- Taxotere
- Alimta
- Gemzar
By Radiotherapy
- External Beam
- Internal
- Systemic
By Targeted Therapies
- Avastin
- Abraxane
- Docetaxel
- Gefitnib
- Tarceva
- Xalkori
- Afatinib
- Dacomitinib
- Talactoferrin
- Iressa
What are the Recent Trends in the Lung Cancer Therapeutics Market?
- Targeted therapy: Targeted therapy has emerged as a significant trend in the treatment of lung cancer. These drugs are designed to target specific proteins or genetic mutations that are involved in the growth and spread of cancer cells.
- Immunotherapy: Immunotherapy is a type of therapy that uses the patient’s immune system to fight cancer. It has shown promising results in the treatment of lung cancer and is now a standard of care for some patients.
- Combination therapy: Combination therapy, which involves the use of multiple drugs or treatment modalities, is becoming increasingly popular in the treatment of lung cancer. This approach has been shown to be more effective than single-agent therapy in some cases.
- Personalized medicine: Advances in molecular testing and genomics have led to the development of personalized medicine in lung cancer. By identifying specific genetic mutations, doctors can tailor treatment plans to individual patients for better outcomes.
- Emergence of biosimilars: Biosimilars, which are similar but not identical copies of biologic drugs, have emerged as a cost-effective alternative to expensive biologic drugs used in the treatment of lung cancer.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/4253
By Region Outlook
• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Top Trending Report:
- AT-Home Testing Market: https://www.alliedmarketresearch.com/at-home-testing-market-A31866
- Resuscitation Devices Market: https://www.alliedmarketresearch.com/resuscitation-devices-market-A11454
- Gene Therapy Market: https://www.alliedmarketresearch.com/gene-therapy-market
- 3D Cell Culture Market: https://www.alliedmarketresearch.com/3d-cell-cultures-market
- Molecular diagnostics market: https://www.alliedmarketresearch.com/molecular-diagnostics-market
- Digital Pathology Market: https://www.alliedmarketresearch.com/digital-pathology-market
- MRI Coils Market: https://www.alliedmarketresearch.com/mri-coils-market-A14839
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.